ask="19.88"
ask_size="100"
average_daily_volume="222941"
bid="14.00"
bid_size="200"
book_value="3.21"
change="-0.60"
change_from_200_day_moving_average="7.27"
change_from_50_day_moving_average="3.66"
change_from_52_week_high="-2.87"
change_From_52_week_low="14.05"
change_in_percent="-3.11%"
close="18.69"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.71"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="6537000"
high="19.44"
high_52_weeks="21.56"
last_trade_date="1/13/2017"
last_trade_price="18.69"
last_trade_size="1051"
last_trade_time="4:00pm"
low="18.51"
low_52_weeks="4.64"
market_capitalization="186.02M"
moving_average_200_day="11.42"
moving_average_50_day="15.03"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="19.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+63.60%"
percent_change_from_50_day_moving_average="+24.39%"
percent_change_from_52_week_high="-13.32%"
percent_change_from_52_week_low="+302.80%"
previous_close="19.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.01"
price_per_sales="3396.67"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="6.60"
stock_exchange="NGM"
symbol="ZYNE"
volume="177964"
weeks_range_52="4.64 - 21.56"
